Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.

Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B; LEAD-3 (Mono) Study Group.

Diabetes Obes Metab. 2011 Apr;13(4):348-56. doi: 10.1111/j.1463-1326.2010.01356.x.

2.

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.

Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A; LEAD-3 Study Group.

Diabetes Obes Metab. 2010 Jul;12(7):604-12. doi: 10.1111/j.1463-1326.2010.01196.x.

3.

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group.

Lancet. 2009 Feb 7;373(9662):473-81. doi: 10.1016/S0140-6736(08)61246-5. Epub 2008 Sep 24.

PMID:
18819705
4.

Appropriate and inappropriate prescribing of narcotics for ambulatory HIV-positive patients.

Morrison RE, Brint JM, Smith WR, Arheart KL, Wray D, Palte SB, Ackerman TF.

J Gen Intern Med. 1994 Jun;9(6):301-5.

PMID:
8077993
5.

Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine.

Lancaster DJ, Palte S, Ray D.

J Acquir Immune Defic Syndr. 1993 May;6(5):533-4. No abstract available.

PMID:
8483118
6.

Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.

Stein DS, Stevens RC, Terry D, Laizure SC, Palte S, Lancaster DJ, Weems JJ, Williams CL.

Antimicrob Agents Chemother. 1991 Sep;35(9):1705-9.

7.

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

Hughes WT, Kennedy W, Shenep JL, Flynn PM, Hetherington SV, Fullen G, Lancaster DJ, Stein DS, Palte S, Rosenbaum D, et al.

J Infect Dis. 1991 Apr;163(4):843-8.

PMID:
2010637
8.

Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone.

Hughes WT, Kennedy W, Dugdale M, Land MA, Stein DS, Weems JJ Jr, Palte S, Lancaster D, Gidan-Kovnar S, Morrison RE.

Lancet. 1990 Oct 27;336(8722):1066. No abstract available.

PMID:
1977035
9.

The pattern of HIV infection in a southern state and city: a model for the outpatient clinic.

Palte SB, Lancaster DJ, Miller ST, Morrison RE, Bobo L.

J Tenn Med Assoc. 1990 Jul;83(7):339-43. No abstract available.

PMID:
2374415
10.

Indigent health care: the increasing contribution of AIDS to the health care budget deficit.

Palte SB, Lancaster DJ.

J Health Soc Policy. 1990;2(1):47-53.

PMID:
10119068
11.

Adrenal carcinoma. A case report.

Palte SB, Pillans PI.

S Afr Med J. 1985 Jun 22;67(25):1021-2.

PMID:
4012468

Supplemental Content

Loading ...
Support Center